Open access · CC-BY
via OpenAlex
Recent clinical trials with stem cells to slow or reverse normal aging processes
Frontiers in Aging · 2023 · ▲ 27 citations
Abstract
Aging is associated with a decline in the regenerative potential of stem cells. In recent years, several clinical trials have been launched in order to evaluate the efficacy of mesenchymal stem cell interventions to slow or reverse normal aging processes (aging conditions). Information concerning those clinical trials was extracted from national and international databases (United States, EU, China, Japan, and World Health Organization). Mesenchymal stem cell preparations were in development for two main aging conditions: physical frailty and facial skin aging. With regard to physical frailty, positive results have been obtained in phase II studies with intravenous Lomecel-B (an allogeneic bone marrow stem cell preparation), and a phase I/II study with an allogeneic preparation of umbilical cord-derived stem cells was recently completed. With regard to facial skin aging, positive results have been obtained with an autologous preparation of adipose-derived stem cells. A further sixteen clinical trials for physical frailty and facial skin aging are currently underway. Reducing physical frailty with intravenous mesenchymal stem cell administration can increase healthy life expectancy and decrease costs to the public health system. However, intravenous administration runs the risk of entrapment of the stem cells in the lungs (and could raise safety concerns). In addition to aesthetic purposes, clinical research on facial skin aging allows direct evaluation of tissue regeneration using sophisticated and precise methods. Therefore, research on both conditions is complementary, which facilitates a global vision.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fragi.2023.1148926
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Garay, R.P. (2023). Recent clinical trials with stem cells to slow or reverse normal aging processes. <em>Frontiers in Aging</em>. https://doi.org/10.3389/fragi.2023.1148926
Vancouver
Garay RP. Recent clinical trials with stem cells to slow or reverse normal aging processes. Frontiers in Aging. 2023. doi:10.3389/fragi.2023.1148926.
BibTeX
@article{ricardo2023Recent,
title = {Recent clinical trials with stem cells to slow or reverse normal aging processes},
author = {Ricardo Pablo Garay},
journal = {Frontiers in Aging},
year = {2023},
doi = {10.3389/fragi.2023.1148926},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Theoretical and Natural Science 2025
Open access · CC-BY
Adipose-Derived Mesenchymal Stem Cells in Facial Rejuvenation: Mechanisms, Applications, and Challenges
InTech eBooks 2017
Open access · CC-BY
Allogeneic Mesenchymal Stem Cells as a Treatment for Aging Frailty
Ataturk University 2024
Open access · US-GOV
The Effect of Tai Chi Exercise and Receptive Music Therapy Applied to Elderly Individuals on Frailty Levels and Mental Health
2020
Citation only
Stem Cells and Aging
IGI Global eBooks 2025
Citation only
Stem-Cell Therapy for Anti-Aging
The Journals of Gerontology Series A 2017
Open access · CC-BY